CPH 0.00% 0.9¢ creso pharma limited

The thing is, the market cap of this company is huge...

  1. 178 Posts.
    lightbulb Created with Sketch. 98
    The thing is, the market cap of this company is huge comparatively to its financial position. Just looking over the last quarterly shows that while it does generate revenue, it runs at a loss. So MC of ~ 170 million, but the company is running at about a ~ 1.5 million per year loss.

    It looks overvalued and the recent excitement has really overshot the mark in terms of the intrinsic value. So therefore the prescribed value is speculative in nature, e.g. potential for future sales, yet to be realised.

    Receipts from customers $3,043,000

    Net cash from / (used in) operating activities $4,452,000)


    So when the price was around 3 cents, it was about 1/10th of the market cap and probably a more realistic intrinsic value for CPH based of these figures.
 
watchlist Created with Sketch. Add CPH (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.